share_log

瑞穗银行:维持Revance Therapeutics(RVNC.US)评级,由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。

Zhitong Finance ·  May 10 08:15

瑞穗银行:维持Revance Therapeutics(RVNC.US)评级,由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment